|
|
Volumn 31, Issue 2, 2011, Pages 255-258
|
|
Jessner-Kanof disease induced by leflunomide: A dermal variant of cutaneous lupus?
a
|
|
Author keywords
Anakinra; Jessner Kanof disease; Leflunomide; Subacute cutaneous lupus induced
|
|
Indexed keywords
ANTINUCLEAR ANTIBODY;
CHLOROQUINE;
CORTICOSTEROID;
DNA ANTIBODY;
GOLD SALT;
HISTONE ANTIBODY;
LEFLUNOMIDE;
METHOTREXATE;
RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;
RO ANTIBODY;
ADULT;
ARTICLE;
CASE REPORT;
CLINICAL FEATURE;
DERMIS;
DERMOEPIDERMAL JUNCTION;
DISEASE CLASSIFICATION;
DRUG EFFICACY;
DRUG MECHANISM;
DRUG TREATMENT FAILURE;
DRUG WITHDRAWAL;
FEMALE;
HISTOLOGY;
HUMAN;
HUMAN TISSUE;
IMMUNOMODULATION;
JESSNER KANOF DISEASE;
LABORATORY TEST;
PRIORITY JOURNAL;
REMISSION;
RHEUMATOID ARTHRITIS;
SKIN BIOPSY;
SKIN LUPUS ERYTHEMATOSUS;
SUBCUTANEOUS TISSUE;
TH2 CELL;
TREATMENT OUTCOME;
ANTIBODIES, ANTINUCLEAR;
ANTIRHEUMATIC AGENTS;
CHLOROQUINE;
FEMALE;
GOLD;
HUMANS;
INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN;
ISOXAZOLES;
LUPUS ERYTHEMATOSUS, CUTANEOUS;
METHOTREXATE;
MIDDLE AGED;
TREATMENT OUTCOME;
|
|
EID: 79954428209
PISSN: 01728172
EISSN: None
Source Type: Journal
DOI: 10.1007/s00296-009-1169-z Document Type: Article |
|
Times cited : (14)
|
|
References (7)
|
